| Literature DB >> 29431133 |
Tamara S Galloway1, Nigel Baglin2, Benjamin P Lee3, Anna L Kocur3, Maggie H Shepherd4,5, Anna M Steele4,5, Lorna W Harries3.
Abstract
OBJECTIVE: Bisphenol A (BPA) has been associated with adverse human health outcomes and exposure to this compound is near-ubiquitous in the Western world. We aimed to examine whether self-moderation of BPA exposure is possible by altering diet in a real-world setting.Entities:
Keywords: bisphenol A; community; dietary intervention; endocrine disrupting chemical; engaged research; plastic packaging; polycarbonate; public health
Mesh:
Substances:
Year: 2018 PMID: 29431133 PMCID: PMC5829847 DOI: 10.1136/bmjopen-2017-018742
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Characteristics of the study population
| Unadjusted urinary BPA at visit 1 (n=94) | |
| Median (IQR) | 1.01 (2.01) |
| 95% CI | 1.19 to 2.57 |
| Mean (SD) | 1.88 (2.68) |
| No of samples below LoQ (0.1 ng/mL) | 15 |
| Minimum value (ng/mL) | 0.07 |
| Maximum value (ng/mL) | 13.55 |
| Creatinine-adjusted urinary BPA at visit 1 (n=94) | |
| Median (IQR) | 1.22 (1.99) |
| 95% CI | 1.16 to 1.20 |
| Mean (SD) | 1.58 (1.64) |
| No of samples below LoQ (0.1 ng/mL) | 15 |
| Minimum value (ng/mL) | 0.05 |
| Maximum value (ng/mL) | 8.56 |
| Unadjusted urinary BPA at visit 2 (n=94) | |
| Median (IQR) | 1.47 (2.87) |
| 95% CI | 1.59 to 3.97 |
| Mean (SD) | 2.78 (4.64) |
| No of samples below LoQ (0.1 ng/mL) | 12 |
| Minimum value (ng/mL) | 0.07 |
| Maximum value (ng/mL) | 31.2 |
| Creatinine-adjusted urinary BPA at visit 2 (n=94) | |
| Median (IQR) | 1.24 (2.51) |
| 95% CI | 1.21 to 5.01 |
| Mean (SD) | 3.13 (7.36) |
| No of samples below LoQ (0.1 ng/mL) | 12 |
| Minimum value (ng/mL) | 0.04 |
| Maximum value (ng/mL) | 53.42 |
| Unadjusted ΔBPA (n=94) | |
| Median (IQR) | 0.06 (2.09) |
| 95% CI | 0.05 to 1.75 |
| Mean (SD) | 0.90 (3.32) |
| Minimum value | −6.42 |
| Maximum value | 17.64 |
| Adjusted ΔBPA (n=94) | |
| Median (IQR) | 0.05 (2.94) |
| 95% CI | −0.28 to 3.39 |
| Mean (SD) | 1.55 (7.16) |
| Minimum value | −4.47 |
| Maximum value | 50.38 |
| BPA risk score (n=94) | |
| Median (IQR) | 17.0 (11.0) |
| 95% CI | 15.4 to 18.8 |
| Mean (SD) | 17.1 (6.63) |
| Demographics (n=94) | |
| Sex (%) male | 44 |
| Exposure to oestrogens (%) of cohort | 15 |
| BMI, median (IQR) | 20.7 (3.43) |
| BMI, mean (SD) | 21.3 (3.13) |
A complete dataset was available on 94 out of 108 participants. The units of BPA and BMI are ng/mL and kg/m2, respectively. Urinary BPA levels are given both as unadjusted data and as a BPA (ng/mL) to creatinine (mg/mL) ratio.
BMI, body mass index; BPA, bisphenol A; LoQ, limit of quantification.
Figure 1The effect of a ‘real-world’ bisphenol A (BPA) avoidance diet on urinary BPA exposure over a 7-day period. (A) Urinary BPA (ng/mL) adjusted for urinary creatinine was plotted at visit 1 before the intervention and at visit 2 after the intervention. Three extreme outliers have been removed. The trajectories of individual participant measurements are shown. (B) Changes in urinary BPA in ng/mL following the intervention diet are plotted against the self-reported BPA risk score.
Figure 2The effect of baseline urinary bisphenol A (BPA) on the probability of achieving a drop in concentrations following the intervention. This graph illustrates the median urinary BPA adjusted for creatinine at visit 1 prior to the intervention expressed relative to whether or not a reduction in urinary BPA was achieved following the 7-day intervention diet at visit 2. Error bars refer to the IQR of measurement.